4.7 Article

An initial study on the predictive value using multiple MRI characteristics for Ki-67 labeling index in glioma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Molecular subtyping of ependymoma and prognostic impact of Ki-67

Ka Young Lim et al.

Summary: Ependymomas (EPNs) display diverse characteristics in terms of immunophenotypes, genetics, and clinical behavior depending on their anatomical locations. Ki-67 index serves as a key factor in grading EPNs, while gains of chromosome 1q and CDKN2A/2B deletions are associated with poor prognoses.

BRAIN TUMOR PATHOLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Mean apparent propagator-MRI in evaluation of glioma grade, cellular proliferation, and IDH-1 gene mutation status

Yifan Sun et al.

Summary: This study evaluated the feasibility of using MAP-MRI to assess the grade of glioma, Ki-67 expression, and IDH-1 mutation status. The results showed that MAP-MRI could effectively evaluate the microstructural changes, cellular proliferation, and IDH-1 mutation status in different grades of glioma.

EUROPEAN RADIOLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Application of diffusion kurtosis imaging to the study of edema in solid and peritumoral areas of glioma

Jun Qiu et al.

Summary: The study evaluated the use of DKI-derived parameters in assessing changes in solid tumor and peritumoral edema areas in glioma patients, showing potential value in distinguishing high- and low-grade gliomas and in evaluating recurrence and prognosis of gliomas. DKI demonstrated utility in studying high-grade gliomas, particularly in solid tumor and peritumoral edema areas.

MAGNETIC RESONANCE IMAGING (2022)

Review Biochemistry & Molecular Biology

Glioma targeted therapy: insight into future of molecular approaches

Keyang Yang et al.

Summary: Gliomas are common brain tumors originating from glial cells. Treatment and prognosis differ significantly depending on the type of glioma. Traditional targeted therapy approaches have faced challenges, while new methods such as immunotherapy and the tumor microenvironment are gaining interest. More clinical trials are needed to evaluate the feasibility of personalized targeted therapy.

MOLECULAR CANCER (2022)

Article Oncology

Preoperative and Noninvasive Prediction of Gliomas Histopathological Grades and IDH Molecular Types Using Multiple MRI Characteristics

Ningfang Du et al.

Summary: This study explored the correlation between MRI morphological characteristics, apparent diffusion coefficient (ADC) parameters, and pathological grades as well as IDH gene phenotypes of gliomas. Multivariable logistic regression models combining MRI features and ADC parameters were developed to predict glioma grades and IDH mutation status, providing a noninvasive and preoperative approach.

FRONTIERS IN ONCOLOGY (2022)

Article Clinical Neurology

Apparent Diffusion Coefficient to Evaluate Adult Intracranial Ependymomas: Relationship to Ki-67 Proliferation Index

Liu Xianwang et al.

Summary: ADC values can effectively differentiate adult intracranial low-grade ependymomas from anaplastic ependymomas, with ADCmean showing the best distinguishing ability. The negative correlations between ADC values and the Ki-67 proliferation index suggest the potential utility of ADC values in improving preoperative diagnostic accuracy and guiding treatment for these tumors.

JOURNAL OF NEUROIMAGING (2021)

Review Oncology

Clinical practice guidelines for the management of adult diffuse gliomas

Tao Jiang et al.

Summary: The joint guideline committee of Chinese Glioma Cooperative Group, Society for Neuro-Oncology of China, and Chinese Brain Cancer Association has updated the clinical practice guideline to provide recommendations for the diagnosis and management of diffuse gliomas. The guidelines focus on molecular and pathological diagnostics, as well as main treatment modalities including surgery, radiotherapy, and chemotherapy. Additionally, the guidelines integrate results from clinical trials of immune therapies and target therapies as future directions.

CANCER LETTERS (2021)

Review Oncology

Diffuse Glioma Heterogeneity and Its Therapeutic Implications

James G. Nicholson et al.

Summary: Diffuse gliomas are characterized by high levels of genetic, epigenetic, and environmental heterogeneity, leading to extreme phenotypic heterogeneity at the cellular level and resistance to various therapies. The intratumoral heterogeneity and malignant cell state plasticity in gliomas pose significant challenges to the development of novel targeted therapies.

CANCER DISCOVERY (2021)

Article Neurosciences

Assessment of Isocitrate Dehydrogenase 1 Genotype and Cell Proliferation in Gliomas Using Multiple Diffusion Magnetic Resonance Imaging

Yan Xie et al.

Summary: The study demonstrates that dMRI-derived parameters can be used to predict the IDH1 genotype in gliomas, with certain parameters showing great potential in assessing cell proliferation.

FRONTIERS IN NEUROSCIENCE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Glioma grading, molecular feature classification, and microstructural characterization using MR diffusional variance decomposition (DIVIDE) imaging

Sirui Li et al.

Summary: The DIVIDE technique shows promise for characterizing and diagnosing gliomas, with the potential to differentiate between different grades, molecular features, and microstructural characteristics of tumors. The diffusion metrics obtained from DIVIDE imaging are able to accurately distinguish between high-grade and low-grade gliomas, as well as between wild-type and mutated IDH tumors.

EUROPEAN RADIOLOGY (2021)

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Article Multidisciplinary Sciences

Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells

Rikke H. Dahlrot et al.

Summary: In this study, the prognostic value of the Ki-67 labelling index in glioblastomas was investigated with digital pathology and improved immunohistochemical multiplexing. The results showed that the Ki-67 LI increased with increasing WHO grade, but there was no significant association with IDH mutation status or survival in glioblastomas.

SCIENTIFIC REPORTS (2021)

Article Oncology

The Glioma Stem Cell Model in the Era of Single-Cell Genomics

Mario L. Suva et al.

CANCER CELL (2020)

Review Oncology

Immunotherapy for glioma: Current management and future application

Shengchao Xu et al.

CANCER LETTERS (2020)

Article Medicine, Research & Experimental

Radiomic prediction models for the level of Ki-67 and p53 in glioma

Xiaojun Sun et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)

Article Oncology

Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastoma

Eugene Wong et al.

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2019)

Review Radiology, Nuclear Medicine & Medical Imaging

Quantitative magnetic resonance imaging and radiogenomic biomarkers for glioma characterisation: a systematic review

Pohchoo Seow et al.

BRITISH JOURNAL OF RADIOLOGY (2018)

Review Biochemistry & Molecular Biology

Ki-67: more than a proliferation marker

Xiaoming Sun et al.

CHROMOSOMA (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Glioma Infiltration Sign on High b-Value Diffusion-Weighted Imaging in Gliomas and Its Prognostic Value

Qiang Zeng et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Characterization of Active and Infiltrative Tumorous Subregions From Normal Tissue in Brain Gliomas Using Multiparametric MRI

Anahita Fathi Kazerooni et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2018)

Article Pathology

The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis

Sebastian Richards-Taylor et al.

JOURNAL OF CLINICAL PATHOLOGY (2016)

Review Radiology, Nuclear Medicine & Medical Imaging

Bench to bedside molecular functional imaging in translational cancer medicine: to image or to imagine?

A. Mahajan et al.

CLINICAL RADIOLOGY (2015)

Article Oncology

The epidemiology of glioma in adults: a state of the science review

Quinn T. Ostrom et al.

NEURO-ONCOLOGY (2014)

Article Clinical Neurology

Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control

Yang Yuan et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2013)

Article Oncology

Pathological findings and prognostic factors in recurrent glioblastomas

Yoshiko Okita et al.

BRAIN TUMOR PATHOLOGY (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Malignant astrocytic tumors: Clinical importance of apparent diffusion coefficient in prediction of grade and prognosis

Shuichi Higano et al.

RADIOLOGY (2006)

Article Oncology

The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas

Anne Linn Johannessen et al.

PATHOLOGY & ONCOLOGY RESEARCH (2006)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Radiology, Nuclear Medicine & Medical Imaging

Tissue signature characterisation of diffusion tensor abnormalities in cerebral gliomas

SJ Price et al.

EUROPEAN RADIOLOGY (2004)